Last 12mo stats

mentions

voices

$SNDX

Syndax Pharmaceuticals Inc

Share on X

$SNDX

Syndax Pharmaceuticals Inc

Past 12mo:12mentions2voices

Share on X

All voices12 mentions since Sep 2025calls only

Loading price chart…

Frequently asked

Who mentions $SNDX most on Surfaced?

@adamfeuerstein (Adam Feuerstein ✡️) mentions $SNDX most — 9 mentions in the past 12 months.

When was $SNDX first mentioned on Surfaced?

The earliest tracked mention of $SNDX in the Surfaced archive was on Sep 8, 2025.

How many voices track $SNDX?

2 FinTwit voices have mentioned $SNDX 12 times in the past 12 months.

What kind of voices mention $SNDX most?

$SNDX is mentioned most by Biotech voices on Surfaced.

Related stocks

$ABBVAbbVie

$ALLOAllogene Therapeutics

$AMGNAMGEN

$ARVNArvinas

Recent mentions

12 mentions

@jacobpliethDec 8, 2025 · 3:48 PM

Interesting - $KURA reveals it's trying to get the Komzifti QTc prolongation warning removed $SNDX

Open on X

@adamfeuersteinDec 6, 2025 · 9:09 PM

Hello! If you can break away from college football for a moment... #ASH25 Day One recap $SNDX Revuforj frontline AML results $VRTX $CRSP Casgevy in young kids Star Therapeutics - Von Willebrand disease Stand up for Science buttons and a brief STAT event recap https://t.co/in6RTsvyip via @statnews

Open on X

@adamfeuersteinDec 6, 2025 · 6:12 PM

$SNDX posted the Revuforj presentation on its web site https://t.co/KOz4CuIyfe

Open on X

@adamfeuersteinDec 6, 2025 · 4:42 PM

I was in the $SNDX presentation. The Revuforj frontline combination AML data were very well received. #ASH25

Open on X

@jacobpliethNov 27, 2025 · 1:37 PM

If you need some biotech reading over Thanksgiving check out @ApexOnco previews of #ASH25 --> https://t.co/cqsR1AVbPH Starts in just over a week! $ACLX $ONC $CRVS $TERN $KURA $SNDX $CGEM $INCY

Open on X

@adamfeuersteinNov 13, 2025 · 4:36 PM

Kura Oncology $KURA secures approval for leukemia drug, its first https://t.co/auM9dGn08Y $SNDX

Open on X

@adamfeuersteinNov 13, 2025 · 3:46 PM

$KURA Komzifti approved for r/r NPM1 mutated AML. Here's the label: https://t.co/T0ZLLP4K1C Black box safety warning for differentiation syndrome but not for QTc prolongation or TdP. Label does include general warning for QTc prolongation. Will compete with $SNDX Revuforj.

Open on X

@adamfeuersteinOct 24, 2025 · 9:42 PM

@monaco_biotech I told you why $SNDX is down despite the approval. I'm not punishing a ticker. Whether other drugs have black box warnings is irrelevant. What matters here is competition from $KURA 's drug, with a Nov. 30 PDUFA date. The label will tell the tale, but Kura's drug appears to be better tolerated. No QTc issues.

Open on X

@adamfeuersteinOct 24, 2025 · 9:20 PM

Following up: $SNDX closed -8% because the expanded Revuforj label now includes new black-box safety warnings for QTc prolongation and Torsades de Pointes.

Open on X

@adamfeuersteinOct 24, 2025 · 6:43 PM

@PersimmonTI $SNDX I don't see an expanded label available yet, but the CR/CRh rate of 23% in the FDA release is lower than previously reported (26%)

Open on X

@adamfeuersteinOct 24, 2025 · 5:12 PM

$SNDX Revuforj approved for NPM1m AML https://t.co/hK3WuahkI6

Open on X

@jacobpliethSep 8, 2025 · 12:43 PM

Guess who just went into the clinic with a new menin inhibitor $SNDX $KURA $JNJ $AZN https://t.co/J1NxKIddpD

Open on X